Show Summary Details
Page of

Adrenal and Renal-Oncologic Interventions 

Adrenal and Renal-Oncologic Interventions
Chapter:
Adrenal and Renal-Oncologic Interventions
Author(s):

Melissa Flynn

, Nathan Kwok

, and Ronald S. Arellano

DOI:
10.1093/med/9780190276249.003.0044
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 18 September 2019

Oncologic processes commonly involve the kidneys and adrenal glands. Renal cell carcinoma is the primary malignancy that affects the kidney, though other primary and metastatic tumors can also involve the kidneys. In contrast, the adrenal is a site frequently affected by metastatic tumors; indeed, primary adrenal cell carcinomas are extremely rare. A variety of oncologic interventions aim to either diagnose or treat renal and adrenal tumors. This chapter will discuss the role interventional oncology as it pertains to tumors of the kidneys and adrenal glands.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.